×
A Double-Blind, Placebo-Controlled Study Comparing the Effects of Sertraline Versus Amitriptyline in the Treatment of Major Depression PDF
$ 40.00
A Double-Blind, Placebo-Controlled Study Comparing the Effects of Sertraline Versus Amitriptyline in the Treatment of Major Depression PDF quantity
$ 40.00
×
Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury PDF
$ 40.00
Valproate Efficacy for Agitation Management in a Patient With Paroxysmal Sympathetic Hyperactivity Due to Traumatic Brain Injury PDF quantity
$ 40.00
×
Increased Self-Report of Obsessive-Compulsive Behaviors Among Hemodialysis Patients: A Case-Control Study PDF
$ 40.00
Increased Self-Report of Obsessive-Compulsive Behaviors Among Hemodialysis Patients: A Case-Control Study PDF quantity
$ 40.00
×
Diagnosis of Wernicke’s Encephalopathy in Patients With a Psychiatric History: A Case Series and Literature Review PDF
$ 40.00
Diagnosis of Wernicke’s Encephalopathy in Patients With a Psychiatric History: A Case Series and Literature Review PDF quantity
$ 40.00
×
Clinical and Genetic Predictors of Delayed Remission After Multiple Levels of Antidepressant Treatment: Toward Early Identification of Depressed Individuals for Advanced Care Options PDF
$ 40.00
Clinical and Genetic Predictors of Delayed Remission After Multiple Levels of Antidepressant Treatment: Toward Early Identification of Depressed Individuals for Advanced Care Options PDF quantity
$ 40.00
×
Psychiatric Phenotype of the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in Males: Newly Described Fronto-Subcortical Dementia PDF
$ 40.00
Psychiatric Phenotype of the Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) in Males: Newly Described Fronto-Subcortical Dementia PDF quantity
$ 40.00
×
Zoom Dysmorphia and Body Dysmorphic Disorder: Regarding Technology Use in Psychiatry and Mental Health PDF
$ 40.00
Zoom Dysmorphia and Body Dysmorphic Disorder: Regarding Technology Use in Psychiatry and Mental Health PDF quantity
$ 40.00
×
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial PDF
$ 40.00
Patients With Early-Phase Schizophrenia Will Accept Treatment With Sustained-Release Medication (Long-Acting Injectable Antipsychotics): Results From the Recruitment Phase of the PRELAPSE Trial PDF quantity
$ 40.00
×
FDA Post-Marketing Safety Decisions PDF
$ 40.00
FDA Post-Marketing Safety Decisions PDF quantity
$ 40.00
×
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak PDF
$ 40.00
Neuropsychiatric Manifestations of Mpox (monkeypox) Virus Amidst a Global Outbreak PDF quantity
$ 40.00
×
Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder PDF
$ 40.00
Weight Change and Metabolic Effects of Asenapine in Patients With Schizophrenia and Bipolar Disorder PDF quantity
$ 40.00
×
Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF
$ 40.00
Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart